Kent Imaging Inc

Kent Imaging Inc specializes in near-infrared fluorescence imaging systems, including the SnapshotNIR and SnapshotGLO series, which help visualize tissue perfusion and wound healing in real time. They also produce single-use surgical drapes, such as the Drape KB100 Series, and tissue saturation oximeters for monitoring oxygen levels in soft tissues. Additionally, they offer reusable imaging devices like the Kent Camera, which pairs with their fluorescence systems for clinical evaluation.

Kent Imaging Inc is based in Canada. The company develops devices intended for both European and U.S. markets, as evidenced by their listings in the EUDAMED registry, FDA’s 510(k) premarket notifications, and the FDA’s Unique Device Identifier (UDI) database. These registries reflect compliance with regulatory requirements in those regions.

Kent Imaging Inc’s devices are listed in the EUDAMED registry under the European Medical Device Regulations, as well as in the FDA’s 510(k) premarket notifications and the FDA’s Unique Device Identifier (UDI) database. These listings indicate their presence in both European and U.S. regulatory frameworks.

Under the EU Medical Device Regulations, Kent Imaging Inc’s devices fall into Class I, Class II, and Class IIa classifications. The classification depends on factors like the intended use, risk level, and interaction with the body—such as imaging systems (often Class IIa) and single-use drapes (typically Class I). The specific classification determines regulatory pathways and compliance requirements.

Kent Imaging Inc’s fluorescence imaging systems, like the SnapshotNIR and SnapshotGLO, are designed specifically for near-infrared fluorescence, which helps assess tissue perfusion, wound healing, and oxygenation in soft tissues. Unlike traditional imaging tools (e.g., X-rays or MRIs), these devices use fluorescence to highlight biological activity in real time, making them unique for intraoperative and postoperative monitoring in surgical settings.